Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
about
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, IndiaUse of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitroSpecific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjectsKinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in bloodImmune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis.Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.Secretory IgA against herpes simplex virus in cervical secretions.Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139.Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine.Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccineInduction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients.Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humansNasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in BangladeshKilled oral cholera vaccines: history, development and implementation challengesSafety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.Vibrio cholerae: lessons for mucosal vaccine design.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccineAntigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine developmentIntranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.Immune responses to cholera in children.Secretory immunity with special reference to the oral cavity.The gastrointestinal immune system: Implications for the surgical patient.Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young childrenCholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea.Small intestinal mucosal protection mechanisms and their importance in rheumatology
P2860
Q21144301-997843E2-A71F-4158-A197-152812258987Q30249278-437FDC5A-57EF-4C38-8668-45E0AFC119A5Q33617401-24EF9430-E6A0-4963-820C-CEB6FEFA038BQ33654645-6A172FA3-23D3-4961-BA5F-8492B5A8F59FQ33716593-5AC6E0A3-95FA-4BB1-8903-C424CF55F7E3Q33756544-4EFC31C0-E472-45EB-9F8F-9336C9C6D287Q33760095-0B4B2BCC-F7B8-40A7-A631-2BE173EA91AEQ33769451-90611056-7469-4C55-BE37-5EDACA194047Q33931901-3B22F77C-25CA-41AB-881C-7987BD7AB075Q33942286-C222F849-914B-4404-9956-B1AC427E9F0CQ33942939-17A80F48-95BC-4ADD-92F4-A456D673F0C9Q33992027-C3B49585-EE6C-4999-AA06-8A9891D7F5A2Q33999035-0C656229-6C5C-4239-B78D-C40C70E46D4FQ34007148-B78E7124-96FB-4F0A-ABD3-0ED3F9760A9DQ34007446-1886C3D0-D3EE-48BC-A6FD-725928EC618AQ34008126-7828A7BF-C551-4421-AD93-245A9D3F552DQ34009698-70453DCD-C73C-476D-839C-900866A8A5CCQ34033623-3E0B2BF8-D425-4377-8242-D7AF1B46A9C4Q34087755-B3714887-D04B-42D5-8107-2AE2B2A6F7ABQ34120919-941B5176-D2EE-42A4-A794-3C89F2F5AA48Q34131647-8AF3C7E7-B109-44C7-987B-3BAA25BDDE6BQ34429327-59BC8305-4672-47E6-9224-5E0F1F03B769Q34562952-6B8DF5F1-BC7F-46C0-9996-3A8487343681Q34883543-24BF2C0D-DF00-4679-8CCD-7CBD32C9913CQ34995847-0EC082A5-AB2E-4AD9-979B-4FAEA37C82E5Q35164830-28D69421-C156-48A0-8F85-A99CE71373EFQ35518719-7A57C2FE-4CCA-453A-8224-0A4517244A5AQ35550710-D2C78977-8E28-4E11-A9B3-1757B72B4F2DQ35689012-B8EA2176-3A50-4F3E-8A21-8F15BCF57869Q36044030-D6B86F40-9D0B-4613-8075-AB7981A201A3Q36678122-D1D91178-A333-428D-B008-A348169C67FCQ36738035-F5D49032-8DBD-4FA2-9EA4-3F75DE852849Q36945363-CA157DA3-8DA2-47B1-ACF4-F38D9D5BF66BQ36949262-C763CBDC-1554-4DFB-AF2B-E6F67445FCCDQ36992602-684962CA-E226-4F99-8E7C-0A8B9F3C16EAQ36992817-14EE57C5-2D08-4FE5-9CAD-4E507CE855D1Q37147641-EB796765-0D21-4618-9B3A-958F25A1A9D3Q37191414-52C9711F-14FF-4568-8E28-4AA4C76F7C99Q37710341-9B94DFD4-B74A-434B-BF20-6AAF8AF8BD9DQ37739505-B4F25240-07B8-4A2A-80C4-D3BF128F4C0E
P2860
Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Saliva, breast milk, and serum ...... vaccination or natural disease
@en
Saliva, breast milk, and serum ...... accination or natural disease.
@nl
type
label
Saliva, breast milk, and serum ...... vaccination or natural disease
@en
Saliva, breast milk, and serum ...... accination or natural disease.
@nl
prefLabel
Saliva, breast milk, and serum ...... vaccination or natural disease
@en
Saliva, breast milk, and serum ...... accination or natural disease.
@nl
P2860
P1476
Saliva, breast milk, and serum ...... vaccination or natural disease
@en
P2093
Jertborn M
P2860
P304
P407
P577
1986-08-01T00:00:00Z